Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells

Journal of Infectious Diseases

Volumn 185, Issue 11, 2002, Pages 1650-1656

  Loeffler, David A ^a,b   Lundy, Steven K ^a,c   Singh, Kameshwar P ^a   Gerard, Herve C ^a   Hudson, Alan P ^a   Boros, Dov L ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EGG; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER GRANULOMA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SERUM; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, HELMINTH; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; OVUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036606495     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340416     Document Type: Article

References (44)

1. Schistosomiasis vaccines: Research to development
2. Interaction of schistosome eggs with vascular endothelium
3. Schistosoma mansoni egg attachment to cultured human umbilical vein endothelial cells: An in vitro model of an early step of parasite egg excretion
4. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs
5. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection
6. Schistosoma mansoni infection in mice depleted of thymus dependent lymphocytes. II. Pathology and altered pathogenesis
7. Altered schistosome granuloma formation in nude mice
8. Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis
9. Etiology of the liver granulomatous response in Schistosoma mansoni-infected athymic nude mice
10. Hepatic vascular lesions in mice infected with Schistosoma mansoni
11. Immunopathology of Schistosoma mansoni infection
12. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: Interactions between schistosome granulomas and the host
13. Hepatic blood flow in mice with acute hepatosplenic schistosomiasis mansoni
14. In vivo microscopic observations of the pathogenesis and pathophysiology of hepatosplenic schistosomiasis in the mouse liver
15. Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation
16. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition
17. Fibrinogen mediated leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
18. Inflammatory granuloma formation is mediated by TNF-α-inducible intercellular adhesion molecule- 1
19. The anatomical picture of the liver in hepato-splenic schistosomiasis mansoni
20. Participation of endothelial cells in murine schistosomiasis
21. Angiogenesis: Models and modulators
22. Eggs of Schistosoma mansoni stimulate endothelial cell proliferation in vitro
23. Vermes I. Apoptosis inducers endotoxin and Fas-ligation enhance the expression of vascular endothelial growth factor in human endothelial cells
24. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway
25. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture
26. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression
27. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
28. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride
29. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures
30. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
31. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
32. Tumor angiogenesis
33. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis
34. Increased expression of vascular endothelial growth factor in pyogenic granulomas
35. MAP kinases and hypoxia in the control of VEGF expression
36. 2+and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells
37. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells
38. Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1-alpha: An autocrine regulation of angiogenesis and inflammatory reactions
39. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
40. Pituitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells
41. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells
42. Regulation of distinct steps of angiogenesis by different angiogenic molecules
43. Tumor angiogenesis
44. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma